Primary male urethral cancer: management and prognosis.
- Author:
Xiao-Fei ZHU
1
;
Kai ZHANG
;
Jie JIN
;
Bing-Wei HUANG
;
Sen LI
;
Jian LIN
Author Information
- Publication Type:Case Reports
- MeSH: Adult; Aged; Chemotherapy, Adjuvant; Humans; Male; Prognosis; Retrospective Studies; Urethral Neoplasms; drug therapy; surgery; therapy
- From: National Journal of Andrology 2012;18(7):615-618
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo further investigate the management and prognosis of primary urethral cancer in male.
METHODSWe treated 3 cases of primary urethral cancer from 2001 to 2011 and followed them up for recurrence and survival.
RESULTSThe 3 male patients all received adjuvant radiotherapy and/or chemotherapy, and 2 of them were treated by distal urethrectomy, while the other underwent no surgery. Follow-up visits revealed 2 cases of metastasis and 1 case of death.
CONCLUSIONPrimary cancer of the male urethra is a rare malignancy with poor prognosis, for which radical resection is the main treatment method. Those in the relatively advanced stage can be treated by a combined method of surgery, radiotherapy and chemotherapy.
